Hyderabad-based Biological E Limited (BE), which recently launched its indigenously made Covid-19 vaccine Corbevax, will focus on new vaccines, specialty injectables, and branded generics.
The funding seeks to establish preclinical and clinical proof of concept for a vaccine designed to provide protection against all known SARS-CoV-2 variants.
The industry body has urged the central government to raise the CSR levy by an additional 1% for a period of 12 months to provide Covid-19 booster vaccines to the community.
The rollout of the vaccine for kids is to be delayed by weeks or months as government wants adequate supplies, distribution infrastructure and fool-proof evidence before inoculating children.